203
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, characterization, X-ray crystal structure and antibacterial activity of nickel, palladium and platinum complexes with Schiff base derived from N-cyclohexylhydrazinecarbothioamide and 5-(tert-butyl)-2-hydroxybenzaldehyde

ORCID Icon, &
Pages 530-537 | Received 08 Jun 2020, Accepted 30 Dec 2020, Published online: 16 Jan 2021
 

Abstract

A new 2-(5-(tert-butyl)-2-hydroxybenzylidene)-N-cyclohexylhydrazine-1-carbothio amide (H2TBNCA) Schiff base ligand has been synthesized contain N, S and O coordinating sites and has been chelated to Ni(II), Pd(II) and Pt(II) metal ions. In all three coordination compounds, the metal ion is in square planar geometry Na[Ni(TBNCA)·OAc], [Pd(TBNCA)·dmso] and [Pt(TBNCA)·dmso] are mononuclear complexes. The structure of H2TBNCA was elucidated by X-ray diffraction analysis. In the broth dilution method, Na[Ni(TBNCA)·OAc] exhibited significant antibacterial activity against Escherichia coli and Staphylococcus aureus with minimum inhibition concentration (MIC) of 12.5 and 6.25 µg mL−1, respectively. [Pt(TBNCA)·dmso] also showed antibacterial activities against E. coli and S. aureus with MIC value of 25 µg mL−1, while [Pd(TBNCA)·dmso] showed lesser activity with MIC values in the range of 50–100 µg mL−1. In the disk diffusion method, the complexes showed significant antibacterial properties against both E. coli and S. aureus, whereas the ligand did not show any significant activity.

GRAPHICAL ABSTRACT

Acknowledgments

The authors wish to thank Universiti Sains Malaysia and The World Academy of Science for (USM-TWAS) fellowship to Md. Azharul Arafath.

Disclosure statement

There are no conflicts of interest to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.